Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma by Subbiah, V., Kuravi, S., Ganguly, S., Welch, D.R., Vivian, C.J., Mushtaq, M.U., Hegde, A., Iyer, S., Behrang, A., Ali, S.M., Madison, R.W., Venstrom, J.M., Jensen, R.A., McGuirk, J.P., Amin, H.M., Balusu, R.

Get full text

TREATMENT‐DEPENDENCE OF HIGH‐RISK GENE EXPRESSION SIGNATURES IN DE NOVO FOLLICULAR LYMPHOMA by Bolen, C.R., Hiddemann, W., Marcus, R., Herold, M., Huet, S., Salles, G., Mattiello, F., Nielsen, T., Mir, F., Venstrom, J.M., Oestergaard, M.Z.

Get full text

EVALUATION OF CLINICOGENETIC RISK MODELS FOR OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN THE PRIMA TRIAL by Huet, S., Szafer‐Glusman, E., Xerri, L., Bolen, C., Punnoose, E., Tonon, L., Tilly, H., Brice, P., Feugier, P., Tesson, B., Viari, A., Venstrom, J.M., Salles, G.

Get full text

Temporary Licensing Of Hyporesponsive NK Cells Following Allogeneic HCT Is Not Affected By T-Cells In The Stem Cell Allograft by Tarek, N, Yu, J, Venstrom, J.M, Hsu, K.C

Get full text

KIR3DL1/S1 and HLA-B Alleles Combine to Influence Unrelated Hematopoietic Stem Cell Transplantation (HSCT) Outcomes by Giglio, F, Venstrom, J.M, Gooley, T.A, Gallagher, M.M, Lebedeva, T, Noreen, H, Rajalingam, R, Reed, E.F, Vierra-Green, C, Yu, N, Haagenson, M, Spellman, S, Malkki, M, Petersdorf, E, Hsu, K.C

Get full text

Donor KIR2DS1 and KIR3DS1 Are Associated With Improved Outcomes Following Unrelated Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia by Venstrom, J.M, Pittari, G, Chewning, J, Gooley, T.A, Spellman, S, Haagenson, M, Gallagher, M.M, Malkki, M, Petersdorf, E, Dupont, B, Hsu, K.C

Get full text

Donor KIR 3DS1 is Associated with Less Acute GvHD Following Unrelated Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies by Venstrom, J.M, Gooley, T.A, Spellman, S.R, Hasan, R.S, Pring, J.A, Malkki, M, Dupont, B, Petersdorf, E.W, Hsu, K.C

Get full text